Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Colin Clancy
Head of Investor Relations
InMed Pharmaceuticals Inc. (INM)Equibles does not estimate personal net worth.
Get an email with a short summary when InMed Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.
Get INM alertsAbout Colin Clancy
Colin Clancy is recorded as Head of Investor Relations at InMed Pharmaceuticals Inc. (INM). InMed Pharmaceuticals Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at InMed Pharmaceuticals Inc. includes Eric Adams (CEO and Board Member), N. Netta "Neeta" Jagpal (CFO), Netta Jagpal (CFO) and 6 others.
Affiliation history
-
Current
Company network
Leadership on record at InMed Pharmaceuticals Inc.
- Eric Adams CEO, Board Member
- N. Netta "Neeta" Jagpal CFO
- Netta Jagpal CFO
- Michael Woudenberg COO
- Sarah Li Chief Accounting Officer
- Bryan Baldasare Board Member
- John Bathery Board Member
- Neil Klompas Board Member
- Nicole Lemerond Board Member
Recent activity
No call appearances or filed executive changes recorded yet.